IVST logo

Innovest Global, Inc. (IVST)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

IVST steht fuer Innovest Global, Inc., ein Industrials-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 16. März 2026
45/100 KI-Bewertung

Innovest Global, Inc. (IVST) Industriebetrieb-Profil

CEOSri Vanamali
HauptsitzChesterland, US
IPO-Jahr2007

Innovest Global, Inc., operating within the industrials sector, focuses on diverse business lines including curtain wall systems, energy services, and biotechnology. With a presence in commercial and industrial sectors, the company also supplies safety equipment and develops immunotherapeutics, positioning itself as a diversified conglomerate.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

Innovest Global, Inc. presents a high-risk, high-reward investment profile due to its presence in multiple sectors, including biotechnology. The company's negative P/E ratio and profit margin of -59.3% indicate financial challenges. Growth catalysts include potential advancements in its immunotherapeutic development and expansion of its energy services. However, the company's OTC listing and negative beta of -0.72 suggest volatility and limited correlation with the broader market. Investors should closely monitor the company's ability to improve profitability and capitalize on its diverse business segments.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Operates in diverse sectors including commercial and industrial, energy, and biotechnology.
  • Gross Margin of 34.0% indicates potential for profitability in specific segments.
  • Negative Profit Margin of -59.3% reflects current financial challenges.
  • Market Cap of $0.00B indicates a micro-cap company with associated risks and potential for growth.
  • Beta of -0.72 suggests a negative correlation with the market, potentially offering diversification benefits.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diversified operations across multiple sectors.
  • Expertise in curtain wall systems design and engineering.
  • Potential for breakthrough in glioblastoma multiforme treatment.
  • Established presence in energy services and safety equipment supply.

Schwaechen

  • Negative profit margin and financial instability.
  • OTC listing indicates higher risk and lower liquidity.
  • Limited market capitalization and brand recognition.
  • Dependence on external factors for energy services demand.

Katalysatoren

  • Upcoming: Potential positive results from clinical trials of its immunotherapeutic for glioblastoma multiforme.
  • Ongoing: Expansion of energy services and securing new contracts.
  • Ongoing: Increased demand for curtain wall systems in commercial construction projects.
  • Ongoing: Strategic partnerships and acquisitions to expand market reach.

Risiken

  • Potential: Failure in clinical trials for its immunotherapeutic development.
  • Potential: Intense competition in all operating sectors.
  • Ongoing: Negative profit margin and financial instability.
  • Ongoing: OTC listing indicating higher risk and lower liquidity.
  • Potential: Economic downturn affecting construction and industrial demand.

Wachstumschancen

  • Expansion of Energy Services: Innovest Global has the opportunity to expand its energy services to meet the growing demand for energy-efficient solutions. The energy services market is projected to reach $120 billion by 2028, driven by increasing awareness of energy conservation and government incentives. By leveraging its expertise in LED lighting and energy brokerage, Innovest can capture a larger share of this market. Timeline: Ongoing.
  • Development of Immunotherapeutic for Glioblastoma Multiforme: The company's development of immunotherapeutic for glioblastoma multiforme represents a significant growth opportunity. The global glioblastoma multiforme treatment market is expected to reach $2.5 billion by 2027. Successful development and commercialization of this therapeutic could generate substantial revenue. Timeline: 3-5 years.
  • Increased Demand for Curtain Wall Systems: Innovest Global can capitalize on the increasing demand for curtain wall systems in commercial and industrial construction. The global curtain wall market is projected to reach $50 billion by 2025, driven by urbanization and the need for energy-efficient building solutions. By enhancing its design and manufacturing capabilities, Innovest can secure more projects. Timeline: Ongoing.
  • Supply of Personal Protective Equipment (PPE): The ongoing need for personal protective equipment (PPE) presents a sustained growth opportunity. The global PPE market is expected to remain strong due to health and safety regulations. Innovest Global can expand its supply chain and distribution network to meet this demand, focusing on quality and competitive pricing. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Innovest Global can pursue strategic partnerships and acquisitions to expand its market reach and service offerings. Collaborating with other companies in the energy, construction, and biotechnology sectors can provide access to new technologies, markets, and expertise. Targeted acquisitions can complement its existing business lines and accelerate growth. Timeline: 1-3 years.

Chancen

  • Expansion of energy services to meet growing demand.
  • Commercialization of immunotherapeutic for glioblastoma multiforme.
  • Increased demand for curtain wall systems in construction.
  • Strategic partnerships and acquisitions to expand market reach.

Risiken

  • Intense competition in all operating sectors.
  • Regulatory changes impacting energy and healthcare industries.
  • Economic downturn affecting construction and industrial demand.
  • Potential failure in clinical trials for immunotherapeutic development.

Wettbewerbsvorteile

  • Diversified business operations across multiple sectors reduces reliance on a single market.
  • Proprietary designs and engineering expertise in curtain wall systems.
  • Established relationships with suppliers and customers in the energy and safety equipment sectors.
  • Potential for intellectual property protection related to its immunotherapeutic development.

Ueber IVST

Innovest Global, Inc., established in 1999 and based in Chesterland, Ohio, operates as a diversified conglomerate engaging in commercial and industrial, energy, and biotechnology and health services sectors. Originally named Aurum Resource and Asset Management, Inc., the company rebranded to Innovest Global, Inc. in January 2017. Its commercial and industrial segment designs, engineers, tests, and manufactures curtain wall systems, along with negotiating and purchasing various exterior building products. It also supplies personal protection equipment, apparel, and safety supplies. In the energy sector, Innovest Global provides energy services aimed at reducing businesses' overall energy costs, offers LED lighting products, and acts as an independent energy broker. The biotechnology and health services segment focuses on developing immunotherapeutics for treating patients with glioblastoma multiforme. The company also offers inbound and outbound call services.

Was das Unternehmen tut

  • Designs, engineers, tests, and manufactures curtain wall systems.
  • Supplies personal protection equipment, apparel, and safety supplies.
  • Offers inbound and outbound call services.
  • Negotiates and purchases various exterior building products.
  • Provides energy services to reduce businesses overall energy costs.
  • Offers LED lighting products.
  • Acts as an independent energy broker.
  • Develops immunotherapeutic for treating patients with glioblastoma multiforme.

Geschaeftsmodell

  • Generates revenue through the sale of curtain wall systems and related engineering services.
  • Earns income from the supply of personal protection equipment and safety supplies.
  • Provides energy services and earns commissions as an independent energy broker.
  • Seeks to generate revenue through the development and potential commercialization of immunotherapeutics.

Branchenkontext

Innovest Global, Inc. operates within the industrials sector, specifically as a conglomerate. This sector is characterized by companies with diverse business operations across multiple industries. The competitive landscape includes companies like BCND, CBCA, LSCG, MEGH and MGLI. Market trends include increasing demand for energy-efficient solutions and advancements in biotechnology. Innovest Global's diversified approach allows it to capitalize on various market opportunities, but also presents challenges in managing diverse operations and maintaining profitability.

Wichtige Kunden

  • Commercial and industrial construction companies requiring curtain wall systems.
  • Businesses seeking to reduce energy costs through energy services and LED lighting.
  • Organizations requiring personal protection equipment and safety supplies.
  • Patients and healthcare providers seeking innovative treatments for glioblastoma multiforme.
KI-Zuversicht: 69% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

Innovest Global, Inc. (IVST) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer IVST verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer IVST.

Kursziele

Wall-Street-Kurszielanalyse fuer IVST.

MoonshotScore

45/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von IVST auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Klassifizierung

Branche Conglomerates

Fuehrung: Sri Vanamali

CEO

Sri Vanamali serves as the CEO of Innovest Global, Inc. His background includes experience in strategic leadership and business development. He has been instrumental in guiding the company through its transition and diversification efforts. His expertise spans across various sectors, including energy, biotechnology, and industrial solutions. Vanamali's leadership focuses on driving innovation and creating shareholder value through strategic initiatives and operational efficiency.

Erfolgsbilanz: Under Sri Vanamali's leadership, Innovest Global, Inc. has focused on diversifying its business operations and exploring new growth opportunities. Key milestones include the expansion of energy services and the development of immunotherapeutic for glioblastoma multiforme. His strategic decisions have aimed to position the company for long-term growth and sustainability, despite current financial challenges.

IVST OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Innovest Global, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater price volatility. Unlike NYSE or NASDAQ listings, OTC Other stocks do not have the same stringent listing requirements, resulting in increased risks for investors due to potential lack of transparency and regulatory oversight.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC stock, IVST likely suffers from low trading volume and wide bid-ask spreads. This can make it difficult for investors to buy or sell shares at desired prices, potentially leading to significant transaction costs and price slippage. The limited liquidity increases the risk of price manipulation and makes it challenging to exit positions quickly.
OTC-Risikofaktoren:
  • Limited financial disclosure and transparency.
  • Potential for price manipulation due to low trading volume.
  • Higher risk of delisting or trading suspension.
  • Lack of regulatory oversight compared to listed exchanges.
  • Increased volatility and wider bid-ask spreads.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Assess the company's management team and their track record.
  • Evaluate the company's business model and competitive landscape.
  • Check for any legal or regulatory issues.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor experienced in OTC stocks.
  • Confirm the company's contact information and physical address.
Legitimitaetssignale:
  • Company has been in operation since 1999.
  • Diversified business operations across multiple sectors.
  • Development of immunotherapeutic for a serious medical condition.
  • Presence in commercial and industrial sectors with tangible products.
  • Company leadership with experience in strategic development.

IVST Industrials Aktien-FAQ

What are the key factors to evaluate for IVST?

Innovest Global, Inc. (IVST) currently holds an AI score of 45/100, indicating low score. Key strength: Diversified operations across multiple sectors.. Primary risk to monitor: Potential: Failure in clinical trials for its immunotherapeutic development.. This is not financial advice.

How frequently does IVST data refresh on this page?

IVST prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven IVST's recent stock price performance?

Recent price movement in Innovest Global, Inc. (IVST) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified operations across multiple sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider IVST overvalued or undervalued right now?

Determining whether Innovest Global, Inc. (IVST) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying IVST?

Before investing in Innovest Global, Inc. (IVST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding IVST to a portfolio?

Potential reasons to consider Innovest Global, Inc. (IVST) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diversified operations across multiple sectors.. Additionally: Expertise in curtain wall systems design and engineering.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of IVST?

Yes, most major brokerages offer fractional shares of Innovest Global, Inc. (IVST) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track IVST's earnings and financial reports?

Innovest Global, Inc. (IVST) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for IVST earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is limited due to OTC status.
  • AI analysis pending for IVST.
Datenquellen

Popular Stocks